↓ Skip to main content

Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease

Overview of attention for article published in Journal of Gastroenterology, September 2011
Altmetric Badge

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
58 Mendeley
Title
Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease
Published in
Journal of Gastroenterology, September 2011
DOI 10.1007/s00535-011-0474-y
Pubmed ID
Authors

Hirotsugu Imaeda, Akira Andoh, Yoshihide Fujiyama

Abstract

The formation of antibodies to infliximab (ATIs) is closely associated with the loss of response to infliximab in patients with inflammatory bowel disease (IBD). We evaluated the clinical utility of a novel method to measure serum ATI levels in the presence of infliximab.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 3%
Unknown 56 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 22%
Student > Master 7 12%
Student > Ph. D. Student 5 9%
Student > Postgraduate 5 9%
Student > Bachelor 4 7%
Other 14 24%
Unknown 10 17%
Readers by discipline Count As %
Medicine and Dentistry 26 45%
Agricultural and Biological Sciences 8 14%
Biochemistry, Genetics and Molecular Biology 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Computer Science 1 2%
Other 3 5%
Unknown 14 24%